KALB MICHAEL WAYNE (EVP & Chief Financial Officer) received a stock award from CINCOR PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/8/2022ACC: 0001209191-22-056126
Officer· EVP & Chief Financial Officer
Since Nov 2022
+103.05K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
103.05K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.44K
Price / share
—
Trade value
—
% of position
New position
11/4/2022
0.00→25.44K
Total
Net shares
+25.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/4/2022 | A · Award | +25.44K | — | — | New position | 0.00 | 25.44K |
| Total | +25.44K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
77.61K shares
Shares
+77.61K
Strike price
30.07
Held after
77.61K
Exercisable
—
11/4/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock77.61K shares | 11/4/2022 | A · Award | +77.61K | 30.07 | — | 77.61K |